IL154532A0 - Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies - Google Patents
Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergiesInfo
- Publication number
- IL154532A0 IL154532A0 IL15453201A IL15453201A IL154532A0 IL 154532 A0 IL154532 A0 IL 154532A0 IL 15453201 A IL15453201 A IL 15453201A IL 15453201 A IL15453201 A IL 15453201A IL 154532 A0 IL154532 A0 IL 154532A0
- Authority
- IL
- Israel
- Prior art keywords
- allergies
- treatment
- vaccine immunogens
- disulphide bridged
- cyclised peptide
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0020717.5A GB0020717D0 (en) | 2000-08-22 | 2000-08-22 | Novel compounds and process |
PCT/EP2001/009576 WO2002016409A2 (en) | 2000-08-22 | 2001-08-17 | Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
Publications (1)
Publication Number | Publication Date |
---|---|
IL154532A0 true IL154532A0 (en) | 2003-09-17 |
Family
ID=9898110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15453201A IL154532A0 (en) | 2000-08-22 | 2001-08-17 | Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040030106A1 (zh) |
EP (1) | EP1311536A2 (zh) |
JP (1) | JP2004514655A (zh) |
KR (1) | KR20030062405A (zh) |
CN (1) | CN1471539A (zh) |
AR (1) | AR030458A1 (zh) |
AU (1) | AU2002214951A1 (zh) |
BR (1) | BR0113439A (zh) |
CA (1) | CA2420086A1 (zh) |
GB (1) | GB0020717D0 (zh) |
HU (1) | HUP0301725A3 (zh) |
IL (1) | IL154532A0 (zh) |
MX (1) | MXPA03001631A (zh) |
NO (1) | NO20030822L (zh) |
PL (1) | PL365788A1 (zh) |
WO (1) | WO2002016409A2 (zh) |
ZA (1) | ZA200301437B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0026334D0 (en) * | 2000-10-27 | 2000-12-13 | Smithkline Beecham Biolog | Vaccine |
GB0209878D0 (en) * | 2002-04-30 | 2002-06-05 | Glaxosmithkline Biolog Sa | Vaccine |
EP1718669A4 (en) * | 2004-02-02 | 2007-10-10 | Tanox Inc | IDENTIFICATION OF NEW IGE EPITOPES |
JP5635771B2 (ja) * | 2006-07-21 | 2014-12-03 | クリスタリア プロデュトス キミコス ファーマシューティコス リミターダ | 抗炎症性及び抗アレルギー性環状ペプチド |
KR101399175B1 (ko) * | 2006-07-21 | 2014-06-19 | 푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 | 항염증성 및 항알레르기성 시클릭 펩티드 |
US20100322945A1 (en) * | 2006-07-26 | 2010-12-23 | Peter Timmerman | Immunogenic compounds and protein mimics |
EP2502072A1 (en) * | 2009-11-16 | 2012-09-26 | F. Hoffmann-La Roche AG | Calibration reagent and uses thereof |
EP2458467B1 (en) | 2010-11-26 | 2013-08-28 | ABB Research Ltd. | Method and system for monitoring an industrial system |
CN106366160B (zh) * | 2016-10-11 | 2019-06-14 | 厦门大学 | 基于二硫键精准配对构建富含二硫键多肽分子骨架的方法 |
EP3779443A4 (en) * | 2018-04-06 | 2022-05-04 | Slsbio Co., Ltd. | NEW IMMUNOGLOBULIN E EPITOPE, BINDING ANTIBODY AND KIT FOR THE ANALYSIS OF IMMUNOGLOBULIN E IN A SAMPLE CONTAINING IT |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981979A (en) * | 1987-09-10 | 1991-01-01 | Neorx Corporation | Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
CA2047078A1 (en) * | 1990-07-19 | 1992-01-20 | Steven S. Bondy | Cyclic hiv principal neutralizing determinant peptides |
TWI227241B (en) * | 1998-06-20 | 2005-02-01 | United Biomedical Inc | IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate |
-
2000
- 2000-08-22 GB GBGB0020717.5A patent/GB0020717D0/en not_active Ceased
-
2001
- 2001-08-17 CA CA002420086A patent/CA2420086A1/en not_active Abandoned
- 2001-08-17 WO PCT/EP2001/009576 patent/WO2002016409A2/en not_active Application Discontinuation
- 2001-08-17 MX MXPA03001631A patent/MXPA03001631A/es unknown
- 2001-08-17 US US10/362,527 patent/US20040030106A1/en not_active Abandoned
- 2001-08-17 PL PL01365788A patent/PL365788A1/xx not_active Application Discontinuation
- 2001-08-17 EP EP01983441A patent/EP1311536A2/en not_active Withdrawn
- 2001-08-17 KR KR10-2003-7002628A patent/KR20030062405A/ko not_active Application Discontinuation
- 2001-08-17 JP JP2002521504A patent/JP2004514655A/ja active Pending
- 2001-08-17 BR BR0113439-6A patent/BR0113439A/pt not_active Application Discontinuation
- 2001-08-17 CN CNA018177778A patent/CN1471539A/zh active Pending
- 2001-08-17 IL IL15453201A patent/IL154532A0/xx unknown
- 2001-08-17 HU HU0301725A patent/HUP0301725A3/hu unknown
- 2001-08-17 AU AU2002214951A patent/AU2002214951A1/en not_active Abandoned
- 2001-08-21 AR ARP010103969A patent/AR030458A1/es unknown
-
2003
- 2003-02-21 ZA ZA200301437A patent/ZA200301437B/en unknown
- 2003-02-21 NO NO20030822A patent/NO20030822L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0113439A (pt) | 2004-07-06 |
NO20030822D0 (no) | 2003-02-21 |
MXPA03001631A (es) | 2004-09-10 |
JP2004514655A (ja) | 2004-05-20 |
CA2420086A1 (en) | 2002-02-28 |
HUP0301725A3 (en) | 2004-11-29 |
AU2002214951A1 (en) | 2002-03-04 |
US20040030106A1 (en) | 2004-02-12 |
WO2002016409A2 (en) | 2002-02-28 |
NO20030822L (no) | 2003-03-31 |
CN1471539A (zh) | 2004-01-28 |
PL365788A1 (en) | 2005-01-10 |
GB0020717D0 (en) | 2000-10-11 |
EP1311536A2 (en) | 2003-05-21 |
WO2002016409A3 (en) | 2002-08-29 |
HUP0301725A2 (hu) | 2003-08-28 |
AR030458A1 (es) | 2003-08-20 |
ZA200301437B (en) | 2004-05-21 |
KR20030062405A (ko) | 2003-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144954A0 (en) | Quinazolines and therapeutic use thereof | |
EE05507B1 (et) | Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks | |
EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
AU1166502A (en) | Human ect2 and methods of use | |
PT1404809E (pt) | Substitutos de pele melhorados e suas utilizações | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
AU2002359512A8 (en) | Belts and methods of use thereof | |
HUP0202150A2 (en) | Use of nitric oxide donors for inducing neurogenesis | |
AU6723401A (en) | Antimicrobial peptides and methods of use thereof | |
EP1578769A4 (en) | PEPTIDES AND THEIR USE TO DARK THE SKIN | |
IL154532A0 (en) | Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies | |
SI1462455T1 (sl) | Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega | |
AU9279601A (en) | Compounds and methods for use thereof in the treatment of cancer or viral infections | |
GB0009344D0 (en) | Fabric treatment article and composition | |
EP1456418A4 (en) | IDENTIFICATION OF NEW POLYMORPHIC LOCATIONS IN THE HUMAN MGLUR8 GEN AND USES THEREOF | |
AU2002363938A8 (en) | Methods and use of motoneuronotropic factors | |
EP1194548A4 (en) | NOVEL PYRRHOCORICIN-DERIVED PEPTIDES AND METHODS OF IMPLEMENTING THE SAME | |
GB2377360B (en) | Hair and garment protector | |
GB0026134D0 (en) | Peptides and their use | |
EP1357129A4 (en) | NEW PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF | |
IL151493A0 (en) | Use of dermaciclane for the treatment of anxiety and depression | |
GB0004534D0 (en) | Hair treatment compositions and their use | |
EP1367123A4 (en) | NEUROTONIN AND ITS USE |